We are live on ! Find out more
APGN

Apexigen, Inc. Common Stock

Delisted

APGN was delisted on the 22nd of August, 2023.

27 hedge funds and large institutions have $37.5M invested in Apexigen, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $33.2M → $37.5M (+$4.22M)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

33% less funds holding

Funds holding: 4027 (-13)

81% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 16

Holders
27
Holders Change
-13
Holders Change %
-32.5%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
8
Reduced
8
Closed
16
Calls
Puts
Net Calls
Net Calls Change

APGN Hedge Fund Activity: Q2 2022 in Review

27 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Apexigen, Inc. Common Stock (APGN) for Q2 2022, worth a combined $37.5M — up 13% from $33.2M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of APGN and 3 opened new positions — a net loss of 13 holders — while 8 trimmed existing stakes and 8 added.

The largest buyer was Mizuho Securities USA, adding an estimated $3.8M. The largest seller was Periscope Capital, cutting an estimated $1.48M.

  • 27 institutional investors held Apexigen, Inc. Common Stock (APGN) as of Q2 2022, down from 40 in Q1 2022.
  • Funds reported $37.5M of Apexigen, Inc. Common Stock stock for Q2 2022, up 13% quarter-over-quarter.
  • 3 funds opened new Apexigen, Inc. Common Stock positions in Q2 2022 and 16 closed out, a net change of -13 holders.
  • The largest Apexigen, Inc. Common Stock buyer in Q2 2022 was Mizuho Securities USA, an estimated $3.8M added.
  • The largest Apexigen, Inc. Common Stock seller in Q2 2022 was Periscope Capital, an estimated $1.48M sold.

Based on aggregated 13F filings for Q2 2022.